| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.18 | 9e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.18 | 0.0001 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |